IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, providing promising developments across several clinical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, more trusted alternative for therapeutic use, significantl